therapy fell sharply. However, the Irish business took in $460 million in dividends from other companies in the group. Gilead Sciences Ireland has wholly-owned subsidiaries in 19 countries across Europe as well as In Australia, New Zealand, China, Singapore, Malaysia, Korea, Russia, Israel and central and South America.
Gilead has operations in Cork and Dublin which between them employ 635 people, according to results filed recently at the Companies Office. The company has a manufacturing, packaging and distribution centre in Cork that is responsible for close to a third of the group’s global supply of oral drugs for conditions like HIV and hepatitis C to around 100 markets worldwide.
Revenues dropped 10 per cent last year to $6.55 billion but that was enough to knock almost 60 per cent of profit after tax, which fell to $241.2 million from $593.5 million in 2022.